- Home
- MRT vs NTHI Comparison
MRT vs NTHI Comparison
Compare MRT & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRT | NTHI |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | Turkey | United States |
| Employees | N/A | 5 |
| Industry | Rental/Leasing Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.0M | 114.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRT | NTHI |
|---|---|---|
| Price | $1.43 | $4.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $3.58 | ★ $15.00 |
| AVG Volume (30 Days) | 55.6K | ★ 89.7K |
| Earning Date | 08-08-2018 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $72.36 | N/A |
| Revenue Next Year | $95.75 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.12 | $3.71 |
| 52 Week High | $3.11 | $12.99 |
Technical Indicators
Market Signals| Indicator | MRT | NTHI |
|---|---|---|
| Relative Strength Index (RSI) | 33.34 | 40.31 |
| Support Level | N/A | $4.17 |
| Resistance Level | $2.26 | $5.78 |
| Average True Range (ATR) | 0.13 | 0.48 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 41.16 | 7.88 |
Price Performance
Historical ComparisonAbout MRT Marti Technologies Inc.
Marti Technologies Inc is Turkiye's urban mobility platform, helping to solve the country's transportation needs through tech-enabled services powered by a single mobility super app. The Group aims to offer tech-enabled urban transportation services to consumers across Turkiye through three service offerings: ride-hailing, delivery, and two-wheeled electric vehicle services. The Group's ride-hailing service matches consumers with car, motorcycle, and taxi drivers. The Group's delivery service provides same-hour package delivery by leveraging the Group's existing network of car and motorcycle drivers and consumer base.
About NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.